FDA-Drug2014-01-22Class II
ETODOLAC Tablet, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 51672401801
Aidapak Services, LLC
Hazard
Labeling: Label Mixup; ETODOLAC, Tablet, 400 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: W003731, EXP: 6/26/2014.
Sold states
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Affected count
101 Tablets
Manufactured in
14301 Se 1st St, Vancouver, WA, United States
Products
ETODOLAC Tablet, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 51672401801
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-601-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief